Catalyst Wire Dossier Catalyst Wire Dossier

ZuraPrep Without IPA

· Zurex Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZuraPrep Without IPA, covering 2014-10-27 to 2015-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA [Phase 1]

See pricing